• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

Juvenile Diabetes Research Foundation (JDRF)

Breakthrough T1D, Mattel debut Barbie doll with type 1 diabetes

July 9, 2025 By Sean Whooley

Breakthrough T1D Mattel Barbie T1D (1)

Breakthrough T1D (formerly JDRF) and Mattel announced a partnership to debut the first Barbie doll with type 1 diabetes (T1D). They say the global collaboration reflects a shared commitment to ensure that people with T1D are “seen, heard and empowered.” It marks another initiative aiming to bring visibility to diabetes, following Insulet and Marvel’s launch […]

Filed Under: Diabetes, Featured Tagged With: Breakthrough T1D, Juvenile Diabetes Research Foundation (JDRF)

8 drug delivery innovations you should know

July 20, 2023 By Sean Whooley

8 drug delivery innovations you need to know 2023

Innovations in drug delivery never stop, and over the past 12 months or so a wide variety have been in the spotlight. Constant progress continues in the diabetes space, both in the form of insulin delivery and other drug delivery methods. Elsewhere, we see implants, patches, syringes and more showcasing the many ways we can […]

Filed Under: Auto-injectors, Business/Financial News, Diabetes, Drug-Device Combinations, Featured, Pharmaceuticals, Technology Tagged With: BD, Beta Bionics, biocorp, Humacyte, Innovation Zed, Insulet, Juvenile Diabetes Research Foundation (JDRF), Micron Biomedical, mit, Schott Pharma, Sernova Inc, Stevanato Group, Tandem Diabetes Care, tidepool, Vivani Medical, Ypsomed

Humacyte, JDRF to develop biovascular pancreas to treat type 1 diabetes

April 27, 2023 By Sean Whooley

JDRF Humacyte

Humacyte (Nasdaq:HUMA) and JDRF announced today that they entered into a collaboration to develop a biovascular pancreas (BVP). The collaboration aims to advance the development of Humacyte’s BVP product candidate for treating type 1 diabetes. Humacyte designed its BVP to deliver insulin-producing islets using its investigational, tissue-engineered blood vessel. The company calls it the Human […]

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Featured, Research & Development Tagged With: Humacyte, Juvenile Diabetes Research Foundation (JDRF)

JDRF launches Type 1 Diabetes Index simulation tool

September 21, 2022 By Sean Whooley

JDRF - updated logo

JDRF announced today that it launched the Type 1 Diabetes Index (T1D Index) data simulation tool for measuring the impact of T1D around the globe. The tool measures the human and public health impact type 1 diabetes has in every country. JDRF said it addresses wide gaps in data about the incidence and impact of […]

Filed Under: Big Data, Business/Financial News, Diabetes, Featured, Technology Tagged With: Juvenile Diabetes Research Foundation (JDRF)

Readout Health wins JDRF grant to evaluate handheld breath ketone monitor

July 12, 2022 By Sean Whooley

Readout Health Biosense Device health app

Readout Health announced today that it entered into a sponsored research agreement with Washington University School of Medicine. The agreement with Washington University School of Medicine (St. Louis) includes a two-year, $360,000 research grant from JDRF to test the efficacy of the Biosense handheld breath ketone monitor in persons with type 1 diabetes during usual […]

Filed Under: Big Data, Business/Financial News, Clinical Trials, Diabetes, Drug-Device Combinations, Featured, Funding Roundup, Patient Monitoring Tagged With: Juvenile Diabetes Research Foundation (JDRF), Readout Health

Aspect Biosystems, JDRF partner to develop bioengineered tissue for type 1 diabetes

April 6, 2022 By Sean Whooley

aspect biosystems

Aspect Biosystems announced today that it entered into a partnership with the Juvenile Diabetes Research Foundation (JDRF). The partnership will support Aspect’s focus on developing a bioengineered tissue therapeutic for type 1 diabetes that will provide insulin independence and control of blood sugar without the need for chronic immune suppression. Vancouver, British Columbia-based Aspect said […]

Filed Under: Diabetes, Featured, Regenerative Medicine Tagged With: Aspect Biosystems, Juvenile Diabetes Research Foundation (JDRF)

FDA approves ready-to-use liquid glucagon from Xeris

September 12, 2019 By Sean Whooley

Xeris Pharmaceuticals logo - updated

Xeris Pharmaceuticals (NSDQ:XERS) said yesterday that the FDA has approved its Gvoke glucagon injection for the treatment of hypoglycemia. Gvoke is a ready-to-use, room-temperature, stable liquid glucagon designed to treat severe hypoglycemia in pediatric and adult patients with Type 1 diabetes aged two years old or above. Chicago-based Xeris’ Gvoke may be administered with a pre-filled […]

Filed Under: Auto-injectors, Clinical Trials, Diabetes, Drug-Device Combinations, Featured, Food & Drug Administration (FDA), Regulatory/Compliance, Wall Street Beat Tagged With: FDA, Juvenile Diabetes Research Foundation (JDRF), xerispharmaceuticals

Researchers tout use of closed-loop insulin delivery system

October 3, 2018 By Sarah Faulkner

JDRF - updated logo

At this year’s meeting of the European Association for the Study of Diabetes, researchers reported that use of a hybrid day-night closed-loop insulin delivery system is better than sensor-augmented pump therapy for blood sugar control in people with poorly controlled Type 1 diabetes. The JDRF-funded study included 44 men and 42 women with Type 1 […]

Filed Under: Clinical Trials, Diabetes, Drug-Device Combinations, Featured, Pharmaceuticals Tagged With: Juvenile Diabetes Research Foundation (JDRF)

SFC Fluidics lands JDRF support for interoperable insulin patch pump

July 30, 2018 By Sarah Faulkner

SFC Fluidics

SFC Fluidics said today that it inked a deal with JDRF to support the development of an insulin patch pump with open-protocol communication features. SFC Fluidics plans to use the two-year funding deal from JDRF to speed up the development of a patch pump that securely connects with other devices, like a continuous glucose monitor […]

Filed Under: Diabetes, Drug-Device Combinations, Featured, Funding Roundup, Pharmaceuticals Tagged With: Juvenile Diabetes Research Foundation (JDRF), sfcfluidics

JDRF tackles insulin consistency, potency at U.S. pharmacies

April 11, 2018 By Sarah Faulkner

diabetes

JDRF is teaming up with the American Diabetes Association and the Leona M. and Harry B. Helmsley Charitable Trust to support research evaluating the consistency and potency of insulin purchased at retail pharmacies in the U.S. The group called for proposals from analytical laboratories to assess the activity of insulin in vials and cartridges, looking […]

Filed Under: Drug-Device Combinations, Featured, Pharmaceuticals, Research & Development Tagged With: americandiabetesassociation, Juvenile Diabetes Research Foundation (JDRF)

  • Page 1
  • Page 2
  • Page 3
  • Go to Next Page »

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy | RSS